Alkon Formulation Profile
Key Indicators
- Authorised Capital ₹ 1.30 Cr
as on 15-11-2024
- Paid Up Capital ₹ 1.30 Cr
as on 15-11-2024
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.47 Cr
as on 15-11-2024
- Revenue 23.46%
(FY 2023)
- Profit 29.44%
(FY 2023)
- Ebitda 6.64%
(FY 2023)
- Net Worth 57.12%
(FY 2023)
- Total Assets 46.70%
(FY 2023)
About Alkon Formulation
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.30 Cr and a paid-up capital of Rs 1.30 Cr.
The company currently has active open charges totaling ₹20.47 Cr.
Anju Kumari, Suresh Saini, and Satya Bharmoria serve as directors at the Company.
- CIN/LLPIN
U74999HP2017PTC006450
- Company No.
006450
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jan 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Alkon Formulation?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anju Kumari  | Director | 12-Jan-2017 | Current |
| Suresh Saini | Director | 12-Jan-2017 | Current |
| Satya Bharmoria | Additional Director | 14-Aug-2020 | Current |
Financial Performance of Alkon Formulation.
Alkon Formulation Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.46% increase. The company also saw a substantial improvement in profitability, with a 29.44% increase in profit. The company's net worth Soared by an impressive increase of 57.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alkon Formulation?
Unlock access to Alkon Formulation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Septy Pharmaceuticals Private LimitedActive 18 years 7 monthsAnju Kumari and Suresh Saini are mutual person
Innocosmetica Wellness LimitedActive 9 months 12 daysAnju Kumari and Suresh Saini are mutual person
- Septy Biosciences Private LimitedActive 2 years 5 months
Anju Kumari and Suresh Saini are mutual person
- Anjushree Lifescience Private LimitedActive 4 years 4 months
Anju Kumari and Suresh Saini are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 02 Jul 2024 | ₹8.70 Cr | Open |
Others Creation Date: 20 Jan 2023 | ₹1.30 Cr | Open |
Axis Bank Limited Creation Date: 22 Oct 2022 | ₹9.66 M | Open |
How Many Employees Work at Alkon Formulation?
Alkon Formulation has a workforce of 22 employees as of Jun 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alkon Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alkon Formulation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
